The 5- and 10-year incidence of testosterone deficiency among testicular cancer survivors was 13.1% and 18.8% compared with 1.2% and 2.9% among the control group, respectively. Chemotherapy was ...

Published in in the American Journal of Preventive Medicine, the study involved responses to the National Health Interview Survey from 2013 to 2017.Researchers studied responses from about 12,000 ...

The 5- and 10-year ED rates in the cancer group were 20.3% and 31.3% ... The 5- and 10-year incidence of testosterone deficiency among testicular cancer survivors was 13.1% and 18.8% ...